3737 Stock Overview
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Zhongzhi Pharmaceutical Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.95 |
| 52 Week High | HK$1.56 |
| 52 Week Low | HK$0.82 |
| Beta | 0.52 |
| 11 Month Change | 0% |
| 3 Month Change | 3.26% |
| 1 Year Change | -33.57% |
| 33 Year Change | -5.94% |
| 5 Year Change | -26.92% |
| Change since IPO | -60.25% |
Recent News & Updates
Recent updates
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding
Aug 22
Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Jun 19Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation
May 10Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
May 05Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
Apr 21Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares
Feb 01These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)
May 06Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues
Apr 21Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?
Mar 29The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More
Mar 05Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 15
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?
Jan 14Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?
Dec 27If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late
Dec 14Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?
Nov 30Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 17Shareholder Returns
| 3737 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 4.4% | 0.07% | -0.6% |
| 1Y | -33.6% | -10.2% | 9.6% |
Return vs Industry: 3737 underperformed the Hong Kong Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 3737 underperformed the Hong Kong Market which returned 10.1% over the past year.
Price Volatility
| 3737 volatility | |
|---|---|
| 3737 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 3737 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 3737's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,736 | Ying Feng Lai | www.zeus.cn |
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands.
Zhongzhi Pharmaceutical Holdings Limited Fundamentals Summary
| 3737 fundamental statistics | |
|---|---|
| Market cap | HK$820.42m |
| Earnings (TTM) | HK$119.56m |
| Revenue (TTM) | HK$2.20b |
6.9x
P/E Ratio0.4x
P/S RatioIs 3737 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3737 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.04b |
| Cost of Revenue | CN¥877.22m |
| Gross Profit | CN¥1.17b |
| Other Expenses | CN¥1.06b |
| Earnings | CN¥111.32m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 57.08% |
| Net Profit Margin | 5.45% |
| Debt/Equity Ratio | 6.7% |
How did 3737 perform over the long term?
See historical performance and comparison